Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 681 to 690 of 1509 total matches.
Drugs for Acne
The Medical Letter on Drugs and Therapeutics • Feb 05, 2024 (Issue 1695)
acne, but it is teratogenic and has many adverse effects.
The Medical Letter ® Vol. 66 (1695) February ...
Acne is common among adolescents and adults.
Guidelines for treatment of acne were last published
by the American Academy of Dermatology in 2016.
Med Lett Drugs Ther. 2024 Feb 5;66(1695):17-20 doi:10.58347/tml.2024.1695a | Show Introduction Hide Introduction
Drugs for Parasitic Infections
Treatment Guidelines from The Medical Letter • Aug 01, 2013 (Issue 143)
: 800-211-2769
Treatment Guidelines from The Medical Letter • Vol. 11 (Suppl) • 2013 e1
AMEBIASIS ...
With increasing travel, immigration, use of immunosuppressive drugs and the spread of AIDS, physicians
anywhere may see infections caused by parasites. The table in this document lists first-choice and alternative drugs for most
parasitic infections.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023 (Issue 1676)
Letter ® Vol. 65 (1676) May 15, 2023
74
Table 1. Efficacy of Contraceptives for Pregnancy Prevention ...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80 doi:10.58347/tml.2023.1676a | Show Introduction Hide Introduction
Drugs for Pneumonia
Treatment Guidelines from The Medical Letter • Sep 01, 2003 (Issue 13)
) is cultured in about 20% of cases (N
Sopena et al, Eur J Clin Microbiol Infect Dis 1999;
Vol. 1 (Issue 13 ...
The choice of drugs for treatment of pneumonia depends on the most likely pathogens causing the infection and local antimicrobial resistance patterns. Factors such as severity of illness, presence of co-morbid conditions and whether the infection is community or hospital-acquired also need to be considered.
Drugs for Breast Cancer
Treatment Guidelines from The Medical Letter • Jan 01, 2005 (Issue 29)
Vol. 3 (Issue 29) January 2005
Published by The Medical Letter, Inc.
1000 Main Street ...
In addition to surgery and radiation therapy, a variety of drugs are used both singly and in combination to treat breast cancer. This article summarizes the principles of adjuvant therapy and treatment for metastatic disease. A summary of individual drugs and their adverse effects begins on page 3.
Pharmaceutical Drug Overdose
Treatment Guidelines from The Medical Letter • Sep 01, 2006 (Issue 49)
or decreased motility.
4
Vol. 4 (Issue 49) September 2006
Published by The Medical Letter, Inc.
1000 ...
Every pharmaceutical drug is a dose-dependent poison. This article describes the clinical presentation and treatment of some dangerous overdoses commonly reported in adults.
Drugs for Cardiac Arrhythmias
Treatment Guidelines from The Medical Letter • Jun 01, 2007 (Issue 58)
is hemodynamically stable) or DC cardioversion.
Vol. 5 (Issue 58) June 2007
Published by The Medical Letter ...
The drugs of choice for treatment of common cardiac arrhythmias are listed in Tables 1 and 2. Some drugs are recommended for indications that have not been approved by the FDA.
Safety of Canadian Drugs
The Medical Letter on Drugs and Therapeutics • Dec 08, 2003 (Issue 1171)
Publication
Vol. 45 (Issue 1171)
December 8, 2003
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna ...
Questions have been raised in the US press recently about the safety of Canadian drugs. The process of drug approval in Canada is similar to that in the US (D Paul, Int J Med Marketing 2001; 1:224). More than 90% of drugs available in Canada have also been approved by the FDA. Most of these drugs come from the same manufacturers as drugs in the US. Health Canada takes longer on average to release drugs than the FDA does; more than half the drugs discontinued for safety reasons by the FDA between 1992 and 2001 had not been approved for use in Canada (NS Rawson and KI Kaitin, Ann Pharmacother...
In Brief: Respiratory Depression with Gabapentinoids
The Medical Letter on Drugs and Therapeutics • Jun 01, 2020 (Issue 1599)
inhibition. Br J
Pharmacol 2018; 175:2492.
The Medical Letter ® Vol. 62 (1599) June 1, 2020
COPD drug ...
The FDA has required new warnings in the labels of
gabapentin (Neurontin, and others) and pregabalin (Lyrica,
Lyrica CR, and generics) about the risk of life-threatening or
fatal respiratory depression in patients with respiratory risk
factors. Respiratory risk factors include chronic obstructive
pulmonary disease (COPD) and concurrent use of opioids
or other CNS depressants. Elderly patients are also at
increased risk.
In Brief: Off-Label Amitriptyline for Insomnia
The Medical Letter on Drugs and Therapeutics • Mar 20, 2023 (Issue 1672)
. Med Lett Drugs
Ther 2010; 52:79.
The Medical Letter ® Vol. 65 (1672) March 20, 2023 mirtazapine ...
In our article on Drugs for Chronic Insomnia, we said
there is little evidence that antidepressants such as
trazodone, mirtazapine, or amitriptyline are effective
in treating insomnia not associated with depression.
We received a comment from a reader who has
prescribed the tricyclic antidepressant amitriptyline
for insomnia, particularly for patients with headache
disorders, and finds that most patients are satisfied
with the treatment.
Med Lett Drugs Ther. 2023 Mar 20;65(1672):48 doi:10.58347/tml.2023.1672d | Show Introduction Hide Introduction